Tuesday, August 3, 2021
wellness India Expo
Home Tags Biologics

Tag: Biologics

Lupin gets US-FDA nod for its Pegfilgrastim biosimilar application

The Biologics License Application (BLA) submission is supported by similarity data from analytical, pharmacokinetic, pharmacodynamic and immunogenicity studies........................

Biocon Biologics to offer its oncology biosimilars in over 30 countries

The company's agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars will enable access to Trastuzumab and Pegfilgrastim in Africa and Asia...................

RDIF & Hetero agree to produce 100 million doses of the...

Currently, Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries, as well as Phase II-III in India..........................

High adoption of biologics to drive Arthritis Therapeutics market gains

Constant rise in the prices of popular drugs such as Humira and Enbrel could shift the focus of patients towards complementary and alternative therapies, thereby narrowing the growth of the arthritis therapeutics market..................

IDBS expands operations in India to capitalize on R&D growth

To manage the firm’s market presence in India, IDBS has appointed Manish Manakchand as Commercial Director and Braj Thakur as National Sales Manager.................

Report points to bright future for biologics & biosimilars

A report on the new review released as part of the ongoing international meet on biotechnology - Global Bio India 2019, noted that the Indian pharmaceutical industry in the country was well geared to take advantage of the emerging situation.............

India’s biosimilars market stays buoyant

The entire gamut of biologic drugs, of which biosimilars are crucial, is set to become an integral part of the future healthcare landscape, writes Shveta Garg while taking us through the current status of the market and future perspectives...............

Role of biologics as advanced treatment option for Psoriatic Arthritis

Overall, studies indicate that biologics remains an effective and safer treatment for longer treatment periods, writes Dr Chandrashekara. S, Professor and Managing Director, ChanRe Rheumatology and Immunology Center and Research, Bengaluru..............

Riding on biologics wave, Biocon registers two fold growth during FY...

For the fiscal year ended March 2019, the Biocon's net profit rose over two-fold to Rs 905.3 crore as against Rs 372.4 crore for 2017-18. Company registered 64% growth in Q4 of FY19, earning 214 cr in net profits.................

ICT Mumbai set to host 5 day workshop on biosimilars characterization

Supported by the BIRAC, the workshop focused on learning of techniques for characterization of biosimilars/biologics will be held from December 11th to 15th at the Institute of Chemical Technology, Mumbai.............